BSEAGM/EGM28 Sept 2026 · 28 Sept 2026, 05:36 pm

PFA

Shree Ganesh Biotech (India) Ltd · 539470

✦ AI SummaryResults

Shree Ganesh Biotech (India) Ltd has informed about the outcome of its 16th Annual General Meeting (AGM) held on September 28, 2026, where two ordinary resolutions were passed, including the adoption of audited financial statements for FY 2025-26 and the re-appointment of Mr. Aman Patel as a director.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Attachments (1)

📄

4b59aa3e-2f27-418a-8265-0b94c51df62b.pdf

pdf

Download →
View document text
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar Date: 28.09.2026 To, To, To, Listing Department, The Secretary, Head - Listing BSE Limited, The Calcutta Stock Metropolitan Stock Exchange of P J Tower, Dalal Exchange Ltd, India Limited Street 7, Lyons Range, Vibgyor Towers, 4th floor, Plot Mumbai-400001 Kolkata - 700001 No C 62, Opp. Trident Hotel Bandra Kurla Complex, Bandra (E), Mumbai – 400098 Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES Dear Sir/Madam, Subject: Proceedings of 16th Annual General Meeting of the Company held on 28th September 2026 In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we hereby inform you that the following businesses were transacted at the Annual General Meeting of the Company held on Monday the 28th September 2026 at 03:00 P.M. at registered office of the company. 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2026 and Reports of the Directors and Auditors thereon. 2. Ordinary Resolution for re-appointment of Mr. Aman Patel (DIN: 08483544), as director of the Company who retires by rotation. The above businesses were transacted and passed by the shareholders at Annual General Meeting. The AGM commenced at 03:00 P.M and concluded at 03:30 P.M. Details of voting results as required under Regulation 44(3) of Listing Regulations are being submitted separately. SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar Kindly take note of the above. Thanking you, Yours faithfully, For, SHREE GANESH BIO-TECH (INDIA) LIMITED Aman Patel Whole-Time Director